Show
Sort by
-
ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males
-
Investigation, treatment and monitoring of late-onset hypogonadism in males
-
- Journal Article
- A1
- open access
Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
-
Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
-
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males
-
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
-
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
-
Investigation, treatment and monitoring of late-onset hypogonadism in males ISA, ISSAM, and EAU recommendations
-
Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients.
-
Experimental gerontology in Belgium: from model organisms to age-related pathologies.